Skip to main content
. 2017 Jan 21;8(9):15610–15620. doi: 10.18632/oncotarget.14779

Figure 4.

Figure 4

Kaplan Meier survival estimates based on immunohistochemical FAS expression both for recurrence free survival A. and overall survival B. Furthermore, the prognostic effect of CD8-positive TILs is shown in both ER-negative (C. RFS, D. OS) and ER-positive tumors (E. RFS, F. OS). P-values represent log-rank survival test.